Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
As of today, Merck(MRK) shares are valued at $107.60. The company's market cap stands at 268.49B, with a P/E ratio of 14.31 and a dividend yield of 3.0%.
As of 2026-01-26, Merck(MRK) stock has fluctuated between $107.60 and $108.30. The current price stands at $107.60, placing the stock 0.0% above today's low and -0.6% off the high.
The Merck(MRK)'s current trading volume is 21.94K, compared to an average daily volume of 11.76M.
In the last year, Merck(MRK) shares hit a 52-week high of $112.90 and a 52-week low of $73.31.
In the last year, Merck(MRK) shares hit a 52-week high of $112.90 and a 52-week low of $73.31.
MRK News
Erasca Inc. (NASDAQ:ERAS) stock is trading lower on Monday, though there is no news to justify the movement. Erasca stock is trading close to the upper end of...
Merck & Co., Inc. (NYSE:MRK) has reportedly ended discussions to acquire cancer drug developer Revolution Medicines, Inc. (NASDAQ:RVMD) after the two sides disa...
Merck (MRK) has ended discussions about a potential acquisition of biotech firm Revolution Medicines, The Wall Street Journal reported Sunday, citing people fam...
Analyst ratings
55%
of 29 ratingsMore MRK News
Merck (MRK) is no longer in discussions to acquire Revolution Medicines (RVMD), Lauren Thomas and Jonathan Rockoff of Wall Street Journal report, citing people...
Merck has been focused on deals up to $15 billion in size. Brendan McDermid/Reuters Merck MRK -0.92 %decrease; red down pointing triangle is no longer in discu...
In recent days, Merck and Moderna reported five-year follow-up data showing that their personalized mRNA melanoma therapy, when combined with Keytruda, substant...
ImmunityBio (NASDAQ:IBRX), an immunity-focused biotech, closed Friday’s session at $6.45, down 12.13%. The stock is still up 63.29% in the past five days and 20...
Key Points Eli Lilly is at the forefront of the GLP-1 weight loss drug market. The company's leading position is already being tested by Novo Nordisk's GLP-1...
Merck (NYSE:MRK) and Moderna released five-year clinical data on a personalized mRNA cancer vaccine regimen used with Keytruda in high-risk melanoma. The follo...
Biotech and Pharma Streetwise AbbVie Dodged a Patent Disaster, and Shares Gained 460%. Merck and Bristol Myers Are Next. In this article ABBV MRK BMY ABT LLY Me...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.